Q3 2021 13F Holders as of 9/30/2021
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115M
-
Number of holders
-
378
-
Total 13F shares, excl. options
-
67.4M
-
Shares change
-
-860K
-
Total reported value, excl. options
-
$5.17B
-
Value change
-
-$66.3M
-
Put/Call ratio
-
0.23
-
Number of buys
-
191
-
Number of sells
-
-136
-
Price
-
$76.62
Significant Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q3 2021
423 filings reported holding GMED - GLOBUS MEDICAL INC - Class A Stock as of Q3 2021.
GLOBUS MEDICAL INC - Class A Stock (GMED) has 378 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.4M shares
of 115M outstanding shares and own 58.51% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (7.31M shares), BlackRock Inc. (7.3M shares), JANUS HENDERSON GROUP PLC (5.77M shares), WELLINGTON MANAGEMENT GROUP LLP (3.24M shares), STATE STREET CORP (2.12M shares), Capital Research Global Investors (1.96M shares), RTW INVESTMENTS, LP (1.67M shares), Champlain Investment Partners, LLC (1.63M shares), KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (1.55M shares), and AXA S.A. (1.53M shares).
This table shows the top 378 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.